FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16208711000001105: Mysoline 250mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57143801000001110 Mysoline 250mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57143901000001116 Mysoline 250mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mysoline 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Is a Product containing precisely primidone 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Has active ingredient Primidone false Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Has specific active ingredient Primidone true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) Is a Mysoline true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mysoline 250mg tablets (Lexon (UK) Ltd) 60 tablet Has AMP True Mysoline 250mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Lexon (UK) Ltd) 100 tablet Has AMP True Mysoline 250mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start